Welcome to the e-CCO Library!

P456: Magnetic resonance enterography findings at week 46 after biological treatment predict long-term clinical outcomes in Crohn's disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fernandez Clotet, A.(1)*;Ordás, I.(2);Masamunt, M.C.(3);Caballol, B.(3);Rodriguez, S.(4);Panés, J.(3);Ricart, E.(5);Rimola, J.(4);
Created: Friday, 14 July 2023, 11:05 AM
P456: Quality of life is associated with wearable-based physical activity in patients with inflammatory bowel disease: a prospective, observational study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Wiestler*1, F. Kockelmann1, M. Kück2, A. Kerling2, U. Tegtbur2, M. P. Manns1, M. Attaran-Bandarabadi1, O. Bachmann1

Created: Friday, 22 February 2019, 9:41 AM
P456: Risk of malignant tumors in patients with autoimmune diseases on ustekinumab therapy: a systematic review and meta-analysis
Year: 2022
Source: ECCO'22
Authors: Huang, K.(1,2);Zhang, Y.(1,2);Yao, L.(1,2);Zhang, Z.(1,2);Liu, R.(1,2);Cao, Q.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P457 IBD couples and their offspring: a European survey
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Oliveira1, M.P. Costa-Santos1, C. Frias Gomes1, J. Sabino2, A. Sampaio3, L. Avedano4, S. Leone4, J.F. Colombel5, J. Torres1

Created: Thursday, 30 January 2020, 10:12 AM
P457: Biological interventions for induction and maintenance of mucosal healing in ulcerative colitis: A Cochrane systematic review
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Ricciuto1*, A. Al-Darmaki2, M.J. Stewart2, N.S. Ding3, H.H. Shim2, M. Storr4,5, R. Panaccione2, C. Seow2

Created: Thursday, 21 February 2019, 9:14 AM
P457: Complications and disease recurrence after primary ileocecal resection in paediatric Crohn’s disease: a multicentre cohort analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Diederen*1, L. de Ridder2, P. van Rheenen3, V. Wolters4, L. Mearin5, G. Damen6, T. de Meij7, H. van Wering8, L. Tseng1, M. Oomen9, J. de Jong9, M. Benninga1, A. Kindermann1

Created: Friday, 22 February 2019, 9:49 AM
P457: Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Bastida*1, V. Bosó2, M. Aguas1, S. Bejar1, A. Garrido1, M. Iborra1, J. del Hoyo1, L. Tortosa1, D. Muñoz1, R. Marqués2, J. L. Poveda2, P. Nos1

Created: Friday, 22 February 2019, 9:41 AM
P457: Long-term cumulative safety of ustekinumab in bionaive patients with Crohn’s Disease and Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Danese, S.(1);Hanauer, S.B.(2);Jairath, V.(3,4);Mihaly, E.(5);Vicente Lidón, R.(6);Ott, E.(7);Gasink, C.(7);Miao, Y.(8);Ma, T.(8);Marano, C.(8);Sands, B.E.(9);
Created: Friday, 11 February 2022, 3:52 PM
P457: Long-term follow-up of patients with IBD after switching from original adalimumab to adalimumab biosimilar during COVID 19 pandemic
Year: 2021
Source: ECCO'21 Virtual
Authors: Klimova, K.(1);Padilla Suarez, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P457: Rapid faecal calprotectin test and symptom index for monitoring the disease activity in colonic IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Puolanne A.-M.*1, Kolho K.-L.2, Färkkilä M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P457: Treatment duration of ustekinumab in patients with Crohn's disease (CD) and psoriasis (PSO) – real-world evidence from German claims data
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kosa, F.(1);Nair, S.(1);He, J.(1);Lin, X.(1);Di Scala, L.(1);Lehne, M.(2)*;Ghiani, M.(3);Maywald, U.(4);Wilke, T.(3);
Created: Friday, 14 July 2023, 11:05 AM
P458 Association between adalimumab serum levels and level of remission in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Hambli1, S. Rogeau2, N. Duveau3, M. Nachury1, J. Branche1, R. Gérard1, P. Wils1, C. Lauriot Dit Prevost1, T. Lambin1, P. Desreumaux1, M. Labalette2, B. Pariente1

Created: Thursday, 30 January 2020, 10:12 AM
P458: Effect of cognitive behavioural therapy on clinical disease course in adolescents and young adults with inflammatory bowel disease and subclinical anxiety and/or depression: results of a randomised trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. van den Brink1, L. Stapersma2, A. S. Bom1, D. Rizopolous3, J. van der Woude4, R. Stuyt5, D. Hendriks6, J. van der Burg6, R. Beukers7, T. Korpershoek7, S. Theuns7, E. Utens2,8,9, J. Escher*1

Created: Friday, 22 February 2019, 9:41 AM
P458: Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU.
Year: 2021
Source: ECCO'21 Virtual
Authors: Mesonero Gismero, F.(1);Zabana, Y.(2);Fernández-Clotet, A.(3);Núñez, A.(4);Caballol, B.(3);Sola, A.(4);García, M.J.(5);Bertoletti, F.(6);Mínguez, A.(7);Suris, G.(8);Casis, B.(9);Ferreiro-Iglesias, R.(10);Calafat, M.(11);Jiménez, I.(12);Miranda-Bautista, J.(13);Lamuela, L.J.(14);Fajardo, I.(15);Torrealba, L.(16);Nájera, R.(17);Sáiz, R.M.(18);González, I.(19);Vicuña, M.(20);García-Morales, N.(21);Gutiérrez, A.(22);López-García, A.(23);Benítez, J.M.(24);Rubín de Célix, C.(25);Tejido, C.(26);Brunet, E.(27);Hernández, A.(28);Suárez, C.(29);Piquqeras, M.(30);Castaño, A.(31);Ramos, L.(32);Sobrino, A.(33);Rodríguez-Grau, M.C.(34);Elosua, A.(35);Montoro, M.(36);López-Sanromán, A.(1);Barreiro-de Acosta, M.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P458: Long-term outcome of Crohn’s disease complicated by upper gastrointestinal stricture: A GETAID cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Lambin1*, A. Amiot2, J.M. Gornet3, P. Seksik4, D. Laharie5, E. Louis6, C. Giletta7, J. Filippi8, M. Fumery9, G. Cadiot10, G. Pineton de Chambrun11, S. Nahon12, M. Serrero13, B. Coffin14, L. Plastaras15, S. Viennot16, N. Dib17, L. Peyrin-Biroulet18, B. Pariente1

Created: Thursday, 21 February 2019, 9:14 AM
P458: Low adherence to Mediterranean diet is associated with increased adipose tissue in patients with ulcerative colitis (UC) after pouch surgery: a cross sectional study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pfeffer-Gik, T.(1)*;Godny, L.(1);Ollech, J.(1);Wasserberg, N.(2);White, I.(2);Cohen, S.(1);Broitman, Y.(1);Avni-Biron, I.(1);Banai, H.(1);Snir, Y.(1);Yanai, H.(1);Yackobovich Gavan, M.(3,4);Shimon, I.(5);Tsvetov, G.(5);Barkan, R.(1);Dotan, I.(1);
Created: Friday, 14 July 2023, 11:05 AM
P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD audit
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. St. Clair Jones*1, S. Murray2

Created: Friday, 22 February 2019, 9:49 AM
P458: Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN
Year: 2022
Source: ECCO'22
Authors: Yerushalmy-Feler, A.(1);Pujol-Muncunill, G.(2);Martin-de-Carpi, J.(2);Kolho, K.L.(3);Levine, A.(4);Olbjørn, C.(5);Granot, M.(6);Bramuzzo, M.(7);Jonsson Rolandsdotter8, H.(8);Mouratidou, N.(9);Hradsky, O.(10);Scarallo, L.(11);Matar, M.(12);Magen Rimon, R.(13);Rinawi, F.(14);Shalem, T.(15);Najajra, H.(16);de Meij, T.(17);Aloi, M.(18);Velasco Rodríguez-Belvís, M.(19);Alvisi, P.(20);Schneider, A.M.(21);van Rheenen, P.(22);Navas-López, V.M.(23);Kiparissi, F.(24);Barrio, J.(25);Turner, D.(26);Cohen, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P458: Sleep problems in inflammatory bowel disease; When bed becomes a battleground
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Green A.*1, Beale A.2, Fraser A.3, Potokar J.3, Durrant C.1, Barnes M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P459 The impact of latent cytomegalovirus infection on the disease behaviour in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Långvall1, C. Shi1, P. Karling2

Created: Thursday, 30 January 2020, 10:12 AM